locoregional and distant failure. Chemoradiation is used to lower the rate of local recurrence, and adjuvant chemotherapy is used to lower the rate of both systemic and local recurrence. The initial principles of adjuvant chemotherapy were established before
Search Results
John G. Phillips, Theodore S. Hong, and David P. Ryan
Agda Karina Eterovic, Ossama M. Maher, Joya Chandra, Ken Chen, Jason Huse, and Wafik Zaky
in the right cerebellar hemisphere with hydrocephalus ( Figure 1E ). Complete Figure 1. (A) Posttherapy calcification of adrenalectomy and rare viable neuroblastoma cells showing good therapeutic response to adjuvant chemotherapy (hematoxylin
Prajnan Das, Yixing Jiang, Jeffrey H. Lee, Manoop S. Bhutani, William A. Ross, Paul F. Mansfield, and Jaffer A. Ajani
). In addition, the role of radiation in this disease is being further evaluated. Adjuvant Chemotherapy Adjuvant chemotherapy has not consistently been shown to improve overall survival in gastric cancer; Table 2 summarizes some of the early
David M. O’Malley
–IV ovarian cancer is the use of maintenance therapy after first-line primary/adjuvant chemotherapy. For patients who achieve a response after platinum-based first-line chemotherapy (± bevacizumab) for advanced disease, olaparib maintenance is a category 1
Amy A. Kirkham, Karen A. Gelmon, Cheri L. Van Patten, Kelcey A. Bland, Holly Wollmann, Donald C. McKenzie, Taryne Landry, and Kristin L. Campbell
among women receiving adjuvant chemotherapy for early-stage breast cancer who participated in a single-arm intervention trial of structured aerobic and resistance exercise programming compared with a historical cohort of similar patients who did not
Scott M. Schuetze and Michael E. Ray
adjuvant chemotherapy . Ann Surg 1982 ; 196 : 305 – 315 . 7 Potter DA Kinsella T Glatstein E . High-grade soft tissue sarcomas of the extremities . Cancer 1986 ; 58 : 190 – 205 . 8 Pisters PW Harrison LB Leung DH . Long
Katya Losk, Ines Vaz-Luis, Kristen Camuso, Rafael Batista, Max Lloyd, Mustafa Tukenmez, Mehra Golshan, Nancy U. Lin, and Craig A. Bunnell
Background Over the past 50 years, substantial reductions in early breast cancer mortality have been documented due to a combination of earlier detection and to advances in adjuvant treatment. 1 – 4 In particular, adjuvant chemotherapy has
Frank Balis, Daniel M. Green, Clarke Anderson, Shelly Cook, Jasreman Dhillon, Kenneth Gow, Susan Hiniker, Rama Jasty-Rao, Chi Lin, Harold Lovvorn III, Iain MacEwan, Julian Martinez-Agosto, Elizabeth Mullen, Erin S. Murphy, Mark Ranalli, Daniel Rhee, Denise Rokitka, Elisabeth (Lisa) Tracy, Tamara Vern-Gross, Michael F. Walsh, Amy Walz, Jonathan Wickiser, Matthew Zapala, Ryan A. Berardi, and Miranda Hughes
biomarkers, and adverse clinical factors, such as incomplete lung response; these patients are stratified to more intensive therapy with additional chemotherapy agents and RT. Chemotherapy Data show that neoadjuvant and/or adjuvant chemotherapy in
Rodrigo Goncalves and Ron Bose
clinically for early-stage breast cancer to predict recurrence risk and guide adjuvant chemotherapy decisions. Discuss the role of genome sequencing in breast cancer. Breast cancer is a heterogeneous disease with a wide range of outcomes that are not
Bonnie S. Glisson and Cesar A. Moran
resection of LCNEC. These data, which are reviewed by Fernandez and Battafarano 24 were from an era before the common use of adjuvant chemotherapy. The rates for 5-year overall survival and for stage I vary widely, from 13% to 57% and 18% to 88
